This inventor holds 1 USPTO granted patent. Top assignees: Riken Corporation, University of California. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: Shyh-Chyang Luo: Innovator in Tumor Cell Capture Technology
Introduction
Shyh-Chyang Luo is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the area of cancer research. His innovative work focuses on the selective capture and release of circulating tumor cells, which is crucial for early cancer detection and treatment.
Latest Patents
Luo holds a patent for a device titled "Selective capture and stimulated release of circulating tumor cells on nanostructured devices." This device is designed to capture preselected cell types from a fluid sample that includes a variety of cell types. The invention features a substrate with a plurality of nanowires, each having an unattached end. A layer of temperature-responsive material is formed on these unattached ends, allowing for the release of captured cells when the temperature is altered. This innovative approach enhances the efficiency of cell capture and release, which is vital for cancer diagnostics.
Career Highlights
Throughout his career, Shyh-Chyang Luo has worked with esteemed organizations such as Riken Corporation and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Luo has collaborated with notable colleagues, including Hsian-Rong Tseng and Shuang Hou. These partnerships have further advanced his research and development efforts in the biomedical sector.
Conclusion
Shyh-Chyang Luo's innovative work in the field of tumor cell capture technology exemplifies the importance of research and development in cancer diagnostics. His contributions continue to pave the way for advancements in medical technology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile